Esther Rajavelu, See Remarks at Spero Therapeutics, Inc. (SPRO), sold 80,540 shares at $2.37 ($191K) on 2025-11-07, disclosed to the SEC on 2025-11-12.
Open-market sale of $191k SPRO by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.37 | 40,270 | $95K | 50.0% |
| 2 | $2.37 | 40,270 | $95K | 50.0% |
| Total | $2.37 avg | 80,540 | $191K | 100% |
| Filing → |
| SPRO | SELL | 2026-02-04 | $41K | — | Filing → |
| SPRO | SELL | 2025-02-05 | $16K | — | Filing → |
| SPRO | SELL | 2024-11-12 | $53K | — | Filing → |